Company / Book Value per Share
Cytek Biosciences, Inc. Book Value per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$2.658
FY2025
5-year range
-$1.335 / $3.182
FY2021-FY2025
Trend
-13.2%
vs FY2024
Sector context
#134 of 158
Health Care
What the data says
Cytek Biosciences, Inc.'s book value per share of $2.658 is lower than 85% of companies in the Health Care sector (FY2025). Book Value per Share has fluctuated over the past 6 years, ranging from -$1.335 in FY2021 to $3.182 in FY2022.
Based on SEC 10-K filings.
$2.658 in FY2025 with a 3-year CAGR of -5.8%.
Declined from $3.007 to $2.658 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -5.8%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 15% in Health CareTop 85% of 158This company $2.658 Sector average $48.175
▼
-94.5% below sector average
Key checks
Key Insights
- 3-year CAGR of -5.8%, indicating a declining trend.
- In FY2025, book value per share decreased 13.2% year-over-year.
- Ranks #134 out of 158 companies in the Health Care sector.
- Peak book value per share was recorded in FY2022.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.658 | -13.2% |
| FY2024 | $3.063 | +1.9% |
| FY2023 | $3.007 | -5.5% |
| FY2022 | $3.182 | +338.4% |
| FY2021 | -$1.335 | -171.5% |
| FY2020 | -$0.492 | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026